Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning

作者:Nelson Michelle H; Bowers Jacob S; Bailey Stefanie R; Diven Marshall A; Fugle Caroline W; Kaiser Andrew D M; Wrzesinski Claudia; Liu Bei; Restifo Nicholas P; Paulos Chrystal M
来源:Journal for ImmunoTherapy of Cancer, 2016, 4(1): 6.
DOI:10.1186/s40425-016-0110-8
  • 出版日期2016-2-16

全文